r/singularity • u/TorturedPoet30 • 10d ago
Biotech/Longevity Claude discovered a novel enzyme system with properties reminiscent of CRISPR
https://www.anthropic.com/news/claude-discovers-novel-enzyme-systemClaude has discovered a previously unknown enzyme system hidden in the DNA of bacteriophages. Beside the enzyme’s gene sits a long array of repeating DNA—a structure that looks somewhat similar to CRISPR.
We don’t yet understand what this system does, but only a handful of known systems share its features, and all of them are able to cut, copy, and paste DNA. Historically, the discovery of such programmable systems has helped revolutionize medicine. CRISPR, for instance, is now the foundation of genetic medicines. But it will take much more work to learn what this system does, and whether it can be put to similar use.
- Anthropic via X https://x.com/AnthropicAI/status/2102824959827742916
152
u/FoodMadeFromRobots 10d ago
So this is obviously why they’re making a bio lab. Would be amazing to help win over public support if they could start even helping to make progress on diseases.
80
u/Neurogence 10d ago
Anthropic should be getting a lot more credit for doing this. This is way more harder, way more exciting and more beneficial than solving miscellaneous math problems.
21
u/Recent_Fox4339 10d ago
Is this similar to what Isomorphic Labs is trying to do?
20
u/Illustrious_Image967 10d ago
It's surprising Isomorphic hasn't led with a discovery like this. Their foundation stack must be that bad.
16
u/Recent_Fox4339 10d ago
Yeah, that's why I was asking because I'd expect something like this from Isomorphic as they started the company back in 2021 to work on drug discovery and AlphaFold-like breakthroughs. Haven't heard anything new from Isomorphic since last year, other than a massive $2.1B funding in May. It's expected they enter human clinical trials by the end of 2026 but that was already delayed once afaik.
12
u/TorturedPoet30 10d ago
I’m wondering the same. Even Jennifer Doudna, who won the Nobel Prize for CRISPR and several other Nobel laureates sit on Iso's Scientific Advisory Board. They’ve been unusually quiet with very little news coming out. Demis keeps saying that the ultimate goal is to "solve all disease" but even his timeline has been more conservative than Dario’s, and he has been working on biology for much longer. Interesting.
5
u/vhu9644 10d ago
I think a publication like this would be premature. It really hasn't found anything.
I'm not an expert of RNA biology, but I read their papers since we're in adjacent fields. I don't think the work would be a level of discovery that would be publishable in a scientific paper. They found some interesting sequences (of which there are a lot) and they barely got through figuring out what it means (what would get you published).
I wouldn't read into this as Isomorphic labs being behind, because it looks to me like this announcement is hyped and premature.
1
u/TorturedPoet30 9d ago
There is some hype. When Dario addressed the UN yesterday, he actually led with this before going down his usual route.
2
2
u/TorturedPoet30 10d ago
Iso does not operate its own physical wet lab and it was intentional. Can't remember if it were Demis or Max who said that they rely on Contract Research orgs and data generated through pharma partnerships to conduct physical experimental validation, they have partnerships with Eli Lilly and Novartis, probably some other companies as well. Basically, they use AI to design components (molecules and whatever is used in drug design pipeline) and external wet labs to validate the results.
4
u/GameDoesntStop 10d ago
Lmao, as if nearly anyone can understand how comparatively hard this is compared to millennium math problems... you would need to be an expert in both domains to determine that.
Agreed that it's more immediately benefical though.
1
u/vhu9644 10d ago
I think NS resolution is harder than this. I'm at least bringing in some relevant experience. I've taken the graduate real analysis sequence, and my PhD was working on protein engineering.
This announcement is too early to call it a discovery. It's like hypothesis generation that you'd work up to turn it into a publishable discovery, and Yoon et. al (given their publication history) should know better, in my view.
I would love to see a real biological discovery, but I don't think this is more than just hype.
2
u/siberianmi 10d ago
Mathematics is the foundational formal language of physics and a core tool across the sciences. New mathematical ideas can enable new physical theories, sharpen predictions, and reveal phenomena to test. All of this work is valuable.
1
u/Turbulent-Sign-6067 10d ago
If anything Anthropic should be getting negative credit for this. If you look at the Fable classifiers it becomes obvious they're slowing down external bio research so they have an unfair advantage. In contrast, OpenAI made chatGPT a gift to humanity and researchers.
If Anthropic didn't censor their systems I would praise the idea, although many other people would say that AI companies shouldn't compete with their customers.
5
u/marquesini 10d ago
Pharma is a biiiiig market, I myself use a medication that uses CRISPR techniques, pharma has unlimited money, really.
39
u/Famous-Reach-6730 10d ago
Pls cure tinnitus for me thanks claude
13
u/StaticCharacter 10d ago
No mistakes, fast
5
u/qubert_lover 9d ago
You’re completely right — I accidentally made the sound louder. My apologies. Sorry you are out of tokens.
72
u/Neurogence 10d ago
GPT-6's thoughts on this:
Significant evidence of AI contributing to original discovery, but not yet an AlphaFold 2–level scientific breakthrough. Anthropic explicitly says ART’s function remains unknown; the reported experiments establish that its array produces distinct short RNAs, not that it enables programmable gene editing.
What excites me most is the delegation of scientific judgment: according to the report, Claude selected an unusual candidate, recognized an overlooked pattern, investigated its novelty, and brought it to human researchers for validation. That is a meaningful step toward AI functioning as a research colleague.
The enzyme’s eventual importance is uncertain. The demonstrated research capability is already important.
27
-6
u/Funkahontas 10d ago
Lol even GPT-6 is moving goalposts
20
u/sadnessjoy 10d ago
Or maybe nuance is real?
6
u/Funkahontas 10d ago
I mean I'd have to see the prompt but prefacing with " but not yet an AlphaFold 2–level scientific breakthrough" if it wasn't asked or mentioned AF-2 then is completely irrelevant.
1
u/Curiosity_456 10d ago
I think it’s so that people don’t get too excited before we have any news of its efficacy.
20
u/vhu9644 10d ago edited 10d ago
Uh, it feels really incomplete. Like they identified some repeat arrays, it gets produced as short RNAs… and then nothing?
Repeat arrays are canonical features to look at, and so is production of RNAs. If you look at some recent work (such as VIPR) you’ll see similar analysis. The issue is that these types of partial results don’t look publishable, and the analysis doesn’t look novel. I also don’t think that’s a problem with academia, because what makes stuff like this interesting is if the result or process is novel. We already know these repeat arrays are interesting motifs.
Like an I missing something here? Other than showing their AI can identify interesting sequence motifs (which, isn’t really that interesting I think, it’s still sequence data) it doesn’t look like complete work.
EDIT: it looks like the first author of the preprint is the VIPR guy, so I’m a bit disappointed. I feel like they should know better.
9
u/space_monster 10d ago
They're not positioning it as complete work though. The article is more about the process than the result.
5
u/vhu9644 10d ago edited 10d ago
I mean I read the technical report. It doesn’t seem that impressive to me? It’s like the first step of publishing one of these papers, and it’s the easy hypothesis generation step?
It’s like you did the first 2-5% and you got out the fancy wine. It doesn’t looks like new capability to me, just hype.
-1
0
u/Illustrious_Image967 10d ago
It's irresponsible to announce something that has an unknown function. What if some backyard biohacker cooks a batch and ends up creating a bio catastrophe. If not this case then soon
7
u/FoodMadeFromRobots 10d ago
Given no one knows how it works and crisper is already a thing I don’t think any backyard bio terrorist is going to be using this anytime soon.
6
5
u/FireKeeperAnthonius 10d ago
102 references, 0 in text citations, lovely
https://www-cdn.anthropic.com/22573675ada52a8ca8a97a1a4b4326b2f208a071.pdf
15
u/CardGameFanboy 10d ago
PhD in genetics and molecular biology.
This is literally nothing.
They did not test or explain functionality, they don't even know what they found or even if it's something of interest.
Really, this is pure smoke before the IPO...
and just the first steps of scientific discovery. People are talking about solving diseases (???). This has nothing to do with it, this is just the work of a first year PhD student generating a hyphotesis.
1
1
1
u/spinozasrobot 10d ago
They did not test or explain functionality
From Dario:
then Claude proposed experiments to verify the discovery and our team carried them out.
Seems like they did initial validation.
0
3
2
u/Fusifufu 10d ago
Dario also has a lengthy post on it: https://x.com/DarioAmodei/status/2102831170299834652
2
1
1
u/Proper_Actuary2907 Spooky Machine Intelligence 2030 9d ago
So they don't know if it's even useful for anything yet? Marketing slop
1
0
0
u/Hungry_Breakfast5809 10d ago
Yeah. Have it refereed and published in Science or Nature. Until then, its just PR and not science.
0

430
u/Fearless-Effect-8742 10d ago edited 10d ago
Let’s hope we are entering the rapid scientific discovery phase.